most effective glp-1 clinical trials outcomes Q&A: Long-term success of therapies hinges on more than just a prescription SGLTi and GLP-1 in HF

Here, the authors report cryo-EM structures of tirzepatide-bound GIPR and GLP-1R, peptide 20-bound GIPR, GLP-1R and GCGR, revealing the molecular basis of their multiplexed pharmacological actions.

The protective effect appeared particularly strong for endometrial cancer, ovarian cancer and meningioma.

Vegan, gluten-free, non-GMO

Why diabetes drugs are driving tech-like returns in healthcare.

Altimmune (NASDAQ:ALT) management used an appearance at the Goldman Sachs Global Healthcare Conference to outline the companys focus on pemvidutide, its lead metabolic and liver disease drug candidate, and to discuss the planned Phase 3 program in metabolic dysfunction-associated steatohepatitis, o

In the months since we launched the GLP-1 Supply Tracker, theres been news and updates about the GLP-1 shortages